Sign In
Buy RGNX
$6.69
+0.170 (+2.61%)
At Close: Jun 03, 2026
Regenxbio: A Transformative Year
07:08pm, Thursday, 15'th Sep 2022
Due to its tremendous pressure, the 2021/2022 Biotech Bear market knocked out nearly all biotech innovators. Nevertheless, certain rare companies like Regenxbio are defying bear market expectations.
REGENXBIO to Participate in Upcoming Investor Conferences
07:05am, Tuesday, 06'th Sep 2022
ROCKVILLE, Md. , Sept. 6, 2022 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Morgan Stanley 20th Annual Global Heal
REGENXBIO Announces Presentation at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference
07:05am, Wednesday, 10'th Aug 2022
ROCKVILLE, Md. , Aug. 10, 2022 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present at the H.C.
REGENXBIO Inc. (RGNX) CEO Ken Mills on Q2 2022 Results - Earnings Call Transcript
12:11am, Friday, 05'th Aug 2022
REGENXBIO Inc. (NASDAQ:RGNX ) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Vit Vasista - Chief Financial Officer Ken Mills - President & Chief Executive Officer Stev
Earnings Preview: Regenxbio (RGNX) Q2 Earnings Expected to Decline
11:37am, Monday, 01'st Aug 2022
Regenxbio (RGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
REGENXBIO to Host Conference Call on August 3 to Discuss Second Quarter 2022 Financial Results and Recent Operational Highlights
07:05am, Monday, 01'st Aug 2022
ROCKVILLE, Md. , Aug. 1, 2022 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, August 3, 2022, at 4:30 p.m.
Regenxbio: Patience And Regular Homework Are Keys
07:41pm, Tuesday, 12'th Jul 2022
RGNX is proceeding towards becoming a pillar of the gene therapy space for ocular diseases. However, it will need time to get there.
5 Small-Cap S&P Stocks To Buy With The Most Upside
01:44pm, Thursday, 26'th May 2022
The S&P 500 is one of the most popular U.S. stock indices and is often what investors and experts are referring to when they mention the "stock market." However, there's more to the market than large-
REGENXBIO Inc. (RGNX) CEO Ken Mills on Q1 2022 Results - Earnings Call Transcript
10:03pm, Wednesday, 04'th May 2022
REGENXBIO Inc. (NASDAQ:RGNX ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Patrick Christmas - Chief Legal Officer Ken Mills - President and CEO Steve Pakola - Chief Me
REGENXBIO to Participate in Upcoming Investor Conferences
07:05am, Wednesday, 04'th May 2022
ROCKVILLE, Md. , May 4, 2022 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Bank of America Securities 2022 Healthcar
REGENXBIO to Host Conference Call on May 4 to Discuss First Quarter 2022 Financial Results and Recent Operational Highlights
07:05am, Wednesday, 27'th Apr 2022
ROCKVILLE, Md. , April 27, 2022 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will host a conference call on Wednesday, May 4, 2022, at 4:30 p.m.
Regenxbio: Is The Ultimate Catalyst Coming?
01:38pm, Wednesday, 20'th Apr 2022
Regenxbio holds the most powerful gene delivery platform on the planet. The company recently closed a $1.3B deal with AbbVie for the development of RGX314 for wet AMD.
Regenxbio (RGNX) Moves to Buy: Rationale Behind the Upgrade
01:33pm, Thursday, 14'th Apr 2022
Regenxbio (RGNX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
REGENXBIO to Participate in Upcoming Investor Conferences
12:05pm, Wednesday, 09'th Mar 2022 PR Newswire
ROCKVILLE, Md., March 9, 2022 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Barclays Global Healthcare Conference Date: Thursday, March 17, 2022 Location: Loews Miami Beach Hotel, Miami, FL Presentation:…
REGENXBIO to Participate in Upcoming Investor Conferences
07:05am, Wednesday, 09'th Mar 2022
ROCKVILLE, Md., March 9, 2022 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Barclays Global Healthcare Conference
